Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2003
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405175A C60 glucocorticoid and it use
03/26/2003CN1404850A Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1404826A Method for preparing naproxen sodium release tablet
03/26/2003CN1404825A Novel decanoy acetaldelzy sodium intravenous preparation and its preparing method thereof
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103773C 二氮杂萘衍生物 Naphthyridine derivative
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/26/2003CN1103755C Novel structural analogues of vitamin D
03/26/2003CN1103592C Medicinal composition containing 2-(benzylimino)-3-benzyl-1,3-hydrothiazine and its application and preparation method
03/26/2003CN1103591C Medicinal composition of substituted 1,4,5,6-tetrahydro-diazin-[4,5-c] diazine-5-tone compounds and its application and preparation method
03/25/2003US6538151 X-ray diffractogram reflections not coinciding with others; anticonvulsants, analgesics, antipyretics,
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6538021 Method for producing luteolin and luteolin derivatives
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application
03/25/2003US6537996 Substituted pyridine or pyrimidine derivatives
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537977 Anti-inflammatory agent
03/25/2003US6537794 Chemokine
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537524 Inflammatory or obstructive airways disease
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2201723C Colchicine derivatives and the therapeutical use thereof
03/25/2003CA2059783C Salts of 2-(2,6-dichloroanilino)-phenylacetic acid, a process for their preparation and their use for pharmaceutical preparations to be applied locally
03/21/2003WO2002026702A1 Phenoxyphenyl alkane sulfonates
03/21/2003CA2423171A1 Phenoxyphenyl alkane sulfonates
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022870A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022839A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003WO2003022832A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022809A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022271A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003WO2003022255A2 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003WO2003022249A1 New self emulsifying drug delivery system
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003022192A1 Eustachian tube stent
03/20/2003WO2003000195A3 Method and material for treating immune diseases
03/20/2003WO2002102344A3 No-synthase inhibitor and use thereof
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002060393A3 Proteoglycan compositions for treatment of inflammatory conditions
03/20/2003WO2002060373A3 Indole derivatives and their uses as heparanase inhibitors
03/20/2003WO2002047697A8 Fractions of snake blood, their preparation and use as therapeutic agents
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002012245B1 Azabicyclic derivatives and their therapeutic use
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2001087913A9 Method for treating retinal degeneration with purinergic receptor agonists
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003US20030055307 Devices for detection and therapy of atheromatous plaque
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055275 Prevention of neutrophil recruitment
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055111 For use in preparation of medicaments for the treatment of tumors and rheumatoid arthritis
03/20/2003US20030055107 Forms of pharmaceutically active agents and method for manufacture thereof
03/20/2003US20030055102 For therapy of allergic or inflammatory disorders of the eye and nose
03/20/2003US20030055098 Method of treatment
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055091 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
03/20/2003US20030055087 As analgesic
03/20/2003US20030055084 Pharmaceutical compounds and methods of use thereof
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055045 Novel compounds with analgesic effect
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055039 For prophylaxis and therapy of inflammatory disease
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055032 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003US20030055015 Therapy and prophylaxis of diseases
1 ... 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 ... 1272